Eli Lilly has announced that orforglipron (Foundayo), its oral glucagon-like peptide-1 (GLP-1) receptor agonist, is now ...

Eric Schadt, a serial entrepreneur and expert in computational biology, is leaving his post as Chief Scientist at Pathos AI ...

DMD affects approximately 15,000 individuals in the United States and primarily impacts boys. Over time, deterioration of the ...

Johnson & Johnson has secured another approval for its multiple myeloma drug Tecvayli (teclistamab), with the European ...

Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.

Kinvard Bio is one of the few companies seriously trying to change that. It started as a scientific spinout from the Andrew ...

More than 20,000 biotechnology leaders gathered in San Diego for the 2026 BIO International Convention under the theme, ...

Actio is the third acquisition for Jazz in the last few years, coming after it bought Chimerix for $935 million last year and ...

England is one of a handful of countries globally to have already exceeded the WHO benchmark of treating 80% of all known ...

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner ...

But Sohonos has not lived up to its sales potential, despite being the only drug on the market, perhaps owing to relatively ...

Blood disorder specialist Fulcrum Therapeutics has agreed to what amounts to a reverse merger with Slate Medicines, a ...